<DOC>
	<DOCNO>NCT01082003</DOCNO>
	<brief_summary>The main purpose research study determine use Trental Vitamin E decrease incidence severity contracture ( shrink harden tissue surround implant ) associate breast implant reconstruction follow radiation treatment . Another goal find impact Trental Vitamin E implant loss need surgical intervention set chest wall radiation reconstruction . In addition , investigator want evaluate patient 's sense well quality life .</brief_summary>
	<brief_title>Prevention Capsular Contracture Using Trental Vitamin E</brief_title>
	<detailed_description>This single center , 18-month study 30 woman receive Trental ( pentoxifylline ) 400 milligram three time day combination vitamin E , 400 international unit orally twice daily six month . Subjects begin treatment regimen within four week completion radiation treatment remain study drug six month . Following completion active treatment , subject enter twelve-month observational phase trial evaluate change breast tissue use follow objective tool : Bakers Grade Assessment , Visual Analog Scale ( VAS ) , implant revision loss , breast photograph , adverse event assessment Quality Life tool ( SF-12 ) .</detailed_description>
	<mesh_term>Contracture</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<mesh_term>Pentoxifylline</mesh_term>
	<criteria>Female subject &gt; 18 year age Expected survival least &gt; 6 month Undergone mastectomy expander implant reconstruction &gt; 3 week radiation therapy Completed chest wall irradiation past two week Willing stop herbal medication direct physician Willing stop daily use supplemental vitamin E ( Multivitamin vitamin E component acceptable ) Willing travel Legacy Health System facility Agree attend study visit outside standard care visit Normal PTINR subject take Coumadin &lt; 18 year age Pregnant lactating Have final implant place &lt; 3 week start radiation therapy Have evidence ongoing infection implant exposure start radiation therapy Radiation complete 16 day prior study start Retinitis Pigmentosa Unable comply protocol Unable provide write informed consent Unwilling unable stop supplemental vitamin E PTINR outside acceptable range subject take Coumadin Investigator believe study participation , reason best interest patient</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Capsular contracture breast cancer patient</keyword>
</DOC>